Development of Raloxifene Hydrochloride Loaded mPEG-PLA Nanoparticles for Oral Delivery

ABSTRACT

Objectives: Raloxifene hydrochloride is used in the treatment of breast cancer which suffers from poor bioavailability problem i.e., only 2% due to excessive first pass metabolism. Development of a delivery system to overcome its bioavailability problem can be done by using mPEG-PLA polymeric nanoparticles which has many scientific applications. Methods: mPEG-PLA polymer has been prepared and evaluated using NMR, FTIR and GPC. Nanoparticles were prepared using emulsion-diffusion-evaporation technique and drug release patterns were evaluated. Pharmacokinetic study was done using Sprague dawley rats to increase the drugs bioavailability. Analytical method was developed with an LOQ 0.5 μg/ml and LOD 0.167 μg/ml. Results: Nanoparticles were formulated using synthesized mPEG-PLA polymer has a particle size range of 165-180 nm. In vitro release study showed, about 72% of drug was released from nanoparticles over the given time duration and showed sustained release for 20 days following Higuchi kinetics. Pharmacokinetic study showed that drug loaded nanoparticles were having approximately 4.87 times more bioavailability than the free drug. Conclusion: Raloxifene hydrochloride loaded nanoparticles prepared with the synthesized mPEGPLA polymer which can release the drug slowly and were suitable for oral delivery. From pharmacokinetic study, it was observed that raloxifene hydrochloride loaded nanoparticles were found to show an increase of relative oral bioavailability to that of raloxifene hydrochloride suspension.

KEYWORDS

• First pass metabolism
• mPEG-PLA
• Nanoparticles
• Emulsion diffusion
• evaporation method
• Bioavailability and Higuchi diffusion

Showing references and in-text citations exactly as published.

• DOI10.5530/ijper.55.1s.44Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPER.

• Article · VOLUME 55, ISSUE 1SBioactive Compound Bisacurone in the Turmeric Extract (Turcuron) Prevents Non-alcoholic Fatty Liver Disease by Reduction of LipogenesisKuluvar Gouthamchandra, Heggar Venkataramana Sudeep, Amritha Raj, Illuri Ramanaih, Chandrappa Siddappa, Kodimule Shyamprasad · pp. S48–S55Original ArticleSame type: Article
• Article · VOLUME 55, ISSUE 1SSolubility Enhancement of Oxcarbazepine by Melt Sonocrystallization Technique to Increase the BioavailabilityVinayak Shivamurthy Mastiholimath, Gauri Pradeep Mashelkar, Vinodkumar Shirshalappa Mannur, Panchaxari Mallappa Dandagi, Pukar Khanal · pp. S56–S65Original ArticleSame type: Article
• Article · VOLUME 55, ISSUE 1STransdermal Delivery of Fluconazole ß-cyclodextrin Complex Incorporated in Aloe vera Gel for Fungal Therapy: Development, Characterization and in vitro EvaluationDeepak Aswal, Tanuja Bisht · pp. S66–S74Original ArticleSame type: Article
• Article · VOLUME 55, ISSUE 1SPreparation, Characterization and Optimization of Repurposed Valproic Acid Loaded Carboxymethyl Chitosan Nanoparticles by Box–Behnken Design for Alzheimer ManagementAyush Jaiswal, Senthil Venkatachalam, Anindita De, Bhavesh Namdev, Ravikumar Ramaswamy, Jawahar Natarajan · pp. S75–S86Original ArticleSame type: Article